Abstract
Purpose
Adiponectin is a predominantly adipocyte-derived hormone which influences insulin sensitivity and energy homeostasis through at least two receptors, AdipoR1 and AdipoR2. In animal models, adiponectin may regulate ovarian steroidogenesis, folliculogenesis, and ovulation. The receptors AdipoR1 and AdipoR2 are present in the human ovary, but their regulation is unknown. In these studies, we determined the effects of LH receptor activation on the expression and function of the two adiponectin receptors in human granulosa cells.
Methods
Granulosa cells were obtained at the time of oocyte retrieval in women undergoing in vitro fertilization (IVF). Cells were isolated and cultured for 48 h in DMEM/F12 medium with 5 % FBS and 50 ug/ml gentamicin. Medium was changed to low serum for 12 h and cells were treated with hCG (100 ng/ml), forskolin (30 μMol/L), or FSH (1 IU/ml) for 24 h for mRNA experiments. mRNA was isolated and RT PCR was performed using Taqman assays and quantification with the delta delta CT method. For immunocytochemistry, cells were grown on chamber slides and treated with hCG for 1 to 24 h and fixed with acetone. ICC was performed with polyclonal rabbit primary antibodies followed by alexa fluor goat anti-rabbit antibody and imaging with a fluorescence microscope and Zeiss software analysis. 3β-hydroxysteroid dehydrogenase (3βHSD) enzyme activity was determined by measuring the progesterone produced when cells were provided with an excess of 22-hydroxy-cholesterol as substrate following an incubation with hCG (1 IU/ml) and/or adiponectin (10 ng/ml). Progesterone content in the media was determined by ELISA.
Results
Messenger RNA for the two Adiponectin receptors is differentially regulated by activation of LHR with hCG treatment. AdipoR2 was increased nearly 4-fold (p < 0.05), whereas AdipoR1 expression was not changed by hCG treatment. Treatment with either FSH or forskolin (an activator of cAMP) had similar effects. Basal AdipoR2 protein was fairly low in granulosa cells in culture however treatment of cells with hCG resulted in a discernible increase in immunodetectable cytoplasmic protein as early as 6 h after treatment and was maintained for at least 24 h. The number of cells positive for AdipoR2 at 6 h increased from a basal of 20 % to almost 60 % (p < 0.05). Adiponectin treatment of hCG-primed cells resulted in increased 3βHSD activity by approximately 60 % over hCG alone and more than 3-fold over basal levels.
Conclusions
AdipoR2 is regulated by the LH receptor function via a cAMP dependant mechanism. Increased expression of adipoR2 prior to and following ovulation may contribute to enhanced 3βHSD activity and increased progesterone secretion by the corpus luteum of the ovary. Dysregulation of adiponectin that may occur with PCOS may impair normal progesterone production.
Keywords: Ovary, Granulosa, Adiponectin, Adiponectin receptor, PCOS, Progesterone
Introduction
Adiponectin is a 30 kDA glycoprotein secreted by adipocytes. It is present in measurable levels in the human circulation as multimer complexes and appears to play critical roles in both glucose homeostasis and lipid metabolism [8,19]. In fact, adiponectin is recognized as having unique insulin-sensitizing, anti-inflammatory, and anti- atherogenic properties [18, 23]. Adiponectin signals by binding one of two distinct seven—transmembrane domain containing receptors, known as AdipoR1 and AdipoR2 [29]. Activation of these cell membrane bound receptors can then activate the AMP activated protein kinase (AMPK), peroxisome proliferator activated receptor alpha (PPARα) and mitogen activated protein kinase (MAPK). The relative activation of receptors and downstream signaling can vary in different cell and tissue types. [29].
Interestingly, levels of adiponectin are paradoxically decreased with increasing adiposity [21, 28]. Thus, adiponectin may be an important biologic mediator, linking obesity to inflammation and insulin resistance in addition to its potential roles in the pathogenesis of other weight-related comorbidities such as type 2 diabetes mellitus, and atherosclerosis [9, 11]. Of special importance to reproduction, adiponectin has been implicated in the pathogenesis of the polycystic ovary syndrome (PCOS) [12, 27]. Both lean and obese women with PCOS demonstrate lower circulating levels of adiponectin compared with BMI-matched normal control women, with levels of adiponectin correlating inversely with estimates of insulin resistance [6, 27]. Moreover, single nucleotide polymorphsims in the adiponectin gene are more prevalent in PCOS women compared with non-PCOS controls [12].
Studies also suggest a functional role of adiponectin in reproduction. Adiponectin and its receptors are expressed in the ovary of various species, including pig, chicken and rat [2, 3]. Adiponectin is also present in follicular fluid at levels similar to serum [10, 25]. Adiponectin treatment does not appear to alter the expression of its own receptors in ovarian granulosa cells [10]. However, adiponectin treatment of granulosa cells from pig or rat does influence the expression of several genes associated with steroidogenesis and periovulatory events [2, 10]. AdipoR1 and AdipoR2, but not adiponectin, were expressed in human primary granulosa cells [4]. In addition, adiponectin does not alter cell proliferation or basal steroidogenesis but does augment IGF1 induced effects on human granulosa cells [4]. Although hCG treatment of rats increased the expression of AdipoR1 in whole ovaries, the expression of AdipoR2 was not changed. The temporal effect of gonadotropins on adiponectin receptor expression and function in human granulosa cells is unknown.
The granulosa cells of the dominant and luteinizing follicles express both the gonadotropin receptors FSHR and LHR. These two receptors are very similar and share considerable homology. They are both 7 transmembrane serpentine receptors that both activate cAMP and the protein kinase A signaling pathway via the stimulatory G protein complex (Gs), though they may have differing capabilities to activate other signaling cascades. FSH is the ligand for FSHR, but both LH and hCG can activate the hCG receptor. [15]
In these studies, we determined the role of gonadotropins on the cellular expression and function of adiponectin receptors in human granulosa cells and explored the functional interaction of adiponectin and LH in luteal granulosa cells.
Materials and methods
Isolation and culture of granulosa cells
Human granulosa cells were collected from preovulatory follicles during oocyte retrieval for IVF, under an IRB-approved protocol. Samples were centrifuged (300× g and 600× g, at room temperature for 5 min each). The cells were then brought to a 1 ml volume using culture medium (DMEM/F12 supplemented with 5%FBS and 50ug/ml gentamicin). Cells were further purified by carefully layering the 1 ml cell suspension on top of 5 mls of 45 % Percoll:DMEM/F12 solution and then centrifuged at 300× g for 30 min at 25°Cs. The top 1 ml containing cell layer was carefully removed from the Percoll and washed 2× with 10 ml culture medium at 600× g 5 min at room temperature. The pellet was resuspended in fresh medium (DMEM/F12) and cells were counted in a hemocytometer using trypan blue dye exclusion for viability testing. The cells were plated for 48 h in DMEM/F12 supplemented with selenium (25 nmol/L), human transferrin (5 mg/L), 0.1 % low insulin bovine serum albumin, and 5 % fetal bovine serum. The medium was then replaced with serum-free medium overnight prior to treatment with media containing the specific experimental treatments. Following treatment, cells were collected for RNA isolation or fixed for immunohistochemistry. Human chorionic gonadotropin (hCG), forskolin, selenium, human transferrin and 0.1 % low insulin bovine serum albumin were obtained from Sigma (Sigma-Aldrich Corporation, St Louis, MO). Adiponectin was obtained from Alexis Biochemicals (San Diego CA.).
RNA extraction and RT-PCR
Total RNA was isolated from human granulosa cells using TRIzol reagent (Invitrogen, Grand Island NY) with the PurelinkTM RNA Miniprep according to the manufacturer’s protocol and stored at −80 0C. RNA was quantified by measuring the absorbance at 260 nm and 280 nm. The RT cDNA synthesis reactions were performed using oligo (dT) M-MLV RT (Ambion, Austin TX) under the conditions described by the manufacturer, and PCR products were verified by electrophoresis and sequencing.
For real-time PCR, the TaqMan assay system was used (Applied Biosystems, Foster City CA) with specific probes for TBP (4333769 T), AdipoR1 (Hs00360422_m1), and AdipoR2 (Hs00226105_m1). The real-time PCR reaction was completed on an ABI 7,500 Thermocycler (Applied Biosystems) with 2 min at 50 °C, 10 min at 95 °C, followed by 45 cycles with 15 s at 95 °C (melting) and 1 min at 60 °C(annealing/extension). The CT value was determined for each duplicate reaction using Sequence Detection Software version 1.7a (Applied Biosystems), and comparative analysis was completed using the delta- delta CT method [14]. TBP is a well- characterized housekeeping gene [7] that is expressed at low levels, similar in magnitude to anticipated AdipoR1 and AdipoR2 expression.
Immunohistochemistry
For immunohistochemistry, granulosa cells were plated and grown in chamber slides (Labtec, Napierville IL). Cell were treated with hCG for various times as described prior to fixation with cold acetone. Fixed cells were blocked with BSA and 1 % serum, then slides were incubated with rabbit polyclonal primary antibodies (1:100 dilution; Phoenix Pharmaceuticals Inc, Burlingame CA) overnight at 4 oC in a humidified container. Slides were then washed and incubated with Alexa Fluor goat anti-rabbit antibody (1:1,000 dilution; Invitrogen) for 1 h at room temperature. Slides were mounted with Dapi mounting media (Vector Labs, Inc, Burlingame CA) and imaged, including measuring the mean intensity of fluorescence per cell, with a ZEISS Axiovert 40 with X-Cite Series 120 fluorescence.
Progesterone production from exogenous substrate
The enzyme 3β-hydroxysteroid dehydrogenase (3BHSD) metabolizes pregnenolone to progesterone. When provided with unlimited substrate, the amount of progesterone produced over time serves as an indicator of 3BHSD enzyme activity. In these studies, excess 22-hydroxy- cholesterol (Sigma) was used as a substrate because it readily enters steroidogenic cells and is rapidly converted to progesterone in the presence of 3βHSD ([5, 16]). However the final reaction in the chain mediated by CYP11A1 (SCC) is also needed to cleave the bond between carbons 20 and 22 resulting in pregnenolone.
Granulosa cells were plated as previously described and the plating medium was replaced with serum free medium 24 h prior to the enzyme assay. Six hours prior to the enzyme assay, the cells were changed to serum-free medium containing 1 IU/ml hCG. Following this incubation, the cells were rinsed well and the medium was changed to DMEM/F12 containing 5 mM 22-0H cholesterol as substrate and 10 ng/ml adiponectin in the presence and absence of hCG (1 IU/ml). After 2 h, the media was removed and frozen at −80 °C until the progesterone assay was performed. The cells were collected and assayed for protein content. Data is presented as progesterone produced in nanograms per mg of protein per hour.
Progesterone content of the media was measured using an enzyme-linked immunosorbent assay (ALPCO, Salem NH), according manufacture instructions. The assays were read on a plate reader using standard curves that were created using blank medium as the diluent. All samples were run in duplicate.
Results
Adiponectin receptor mRNA is differentially regulated in granulosa cells treated with gonadotropins
The effects of gonadotropins on the expression of mRNA for AdipoR1 and AdipoR2 were evaluated in cultured granulosa cells (Fig. 1). Both FSH and hCG (as a surrogate for LH) treatment increased AdipoR2 mRNA by more than 2-fold. When cells were treated with forskolin, an activator of adenylate cyclase, an increase in AdipoR2 mRNA of a similar magnitude was observed, supporting that activation of the PKA/cAMP pathway is the mechanism action of gonadotropin regulation of AdipoR2. In contrast, AdipoR1 mRNA was not substantially increased by any of these treatments.
AdipoR2 intracellular protein is increased by treatment with hCG in a time dependant manner
Basal expression of AdipoR2 protein was fairly low in cultured granulosa cells (Fig. 2a). However, treatment with hCG resulted in a discernible increase in immunodetectable cytoplasmic protein as early as 6 h after treatment (Fig. 2c), and was maintained up to 24 h (Fig. 2e). Cells staining positively for AdipoR2 increased from a basal of 20 % to almost 60 % following hCG treatment (Fig. 2g).
Adiponectin enhances 3βHSD activity in granulosa cells treated with hCG
In order to determine if there was a physiological relevance to the regulation of AdipoR2 by gonadotropins, we determined the effect of treatment with adiponectin on hCG-stimulated 3βHSD activity as reflected by timed granulosa cell progesterone production when precursor substrate was provided in excess (Fig. 3). In cells that had been pretreated with hCG for 6 h, adiponectin alone had no effect on 3βHSD activity over basal conditons. As expected, treatment with hCG increased progesterone production, but the combination of adiponectin and hCG increased progesterone production by approximately 60 % over hCG alone and more than 3-fold over basal levels (Fig. 3).
Discussion
In this series of experiments, we have demonstrated that 1) treatment of luteinized granulosa cells with either hCG or FSH upregulates AdipoR2 but not AdipoR1 mRNA expression; 2) hCG treatment of granulosa cells rapidly induces cytoplasmic expression of the AdipoR2; and 3) that adiponectin is able to augment the hCG-stimulated activity of the 3βHSD enzyme. (summarized in Fig. 4). Collectively, these data suggest that adiponectin, working through the AdipoR2 receptor, plays a role in the rapid up-regulation of progesterone secretion after the LH surge. Thus, dysregulation of this system could adversely impact luteal secretion of progesterone.
Although it had been posited that AdipoR1 was the primary adiponectin receptor regulated by gonadotropin in granulosa cells [3], in this study we have demonstrated that the activation of the cAMP pathway by either hCG, FSH or forskolin upregulate expression of AdipoR2 to a much greater extent than AdipoR1 in primary human granulosa cells. This result is in contrast to the response following the injection of intact rats with hCG and evaluating whole ovary expression of the receptors [3]. Specifically, under these circumstances AdipoR1 was greatly upregulated but R2 was not. However, use of whole ovary lysates may have obscured more subtle changes in the granulosa cells of periovulatory follicles. A recent study of mouse ovaries demonstrating that mural and cumulus granulosa cells differentially express the receptors for adiponectin confirms this possibility [22]. It is also possible that there are species-specific differences in the role of the receptors in ovarian cell function or that the state of differentiation of the cultured cells influences adiponectin responses.
In our studies, the basal protein level for AdipoR2 was low in cultured human primary granulosa cells. This is consistent with reports of others that R2 expression is low in both primary cells and the KGN granulosa cell tumor line [3, 20]. However, following treatment with hCG, AdipoR2 expression was increased relatively quickly and remained stably expressed. We are unaware of other reports of the acute effects of hCG stimulation on AdipoR2 expression in human granulosa cells. These acute effects are particularly relevant in a process that is as time dependant as ovulation. The increased availability of LH to dominant follicle granulosa cells in the hours prior to ovulation could stimulate an increase in cytoplasmic AdipoR2 in the periovulatory follicle. Adiponectin is present in follicle fluid, may be produced by oocytes and theca ([1, 3, 13, 24]), and is readily available to dominant follicle mural and cumulus granulosa cells.
We also found that adiponectin treatment of granulosa cells resulted in an acute increase in hCG-stimulated production of progesterone from exogenous substrate, strongly suggesting an effect on the activity of 3BHSD. Interestingly, adiponectin did not have a significant effect on enzyme activity under basal conditions. These findings demonstrate the potential physiologic significance of gonadotropin-stimulated expression of AdipoR2 on the acute effects of adiponectin on 3βHSD activity in granulosa cells and the corpus luteum and suggest that adiponectin may play a role in the rise in progesterone production leading up to and following ovulation.
Taking all of our data together, we propose the following paradigm. The increasing availability of LH to granulosa cells of the dominant follicle during the LH surge results in the rapid upregulation of the expression of functional AdipoR2 receptors. These receptors would then be able to respond to the adiponectin in the follicular fluid and augment the LH stimulated 3βHSD activity, thus increasing early progesterone production by the dominant follicle. Though many factors are known to play roles in augmenting progesterone production by the luteal cells, the association of the adiponectin pathway with progesterone secretion is intriguing because of the known association of obesity and PCOS (states characterized by decreased levels of adiponectin) with ovulatory and luteal dysfunction [17].
Furthermore it has been shown that adiponectin levels can increase in women with PCOS and obesity when they lose weight [26]. Thus, increases in adiponectin levels may contribute to the improved reproductive function observed in women who are successful at weight loss. Although this paradigm likely over simplifies the complex ovarian physiology, our data does encourage further studies of the specific roles of adiponectin signaling in human reproductive physiology including the transition of cells from follicular granulosa cells into corpus luteal cells.
Footnotes
Capsule Adiponectin type two receptor is rapidly upregulated by LH receptor activation via a cAMP dependant mechanism.
Edmond P. Wickham III and Tao Tao contributed equally to the manuscript.
Supported by NICHD HD 045700 and HD034449
References
- 1.Bersinger NA, Wunder DM. Adiponectin isoform distribution in serum and in follicular fluid of women undergoing treatment by ICSI. Acta Obstet Gynecol Scand. 2010;89(6):782–8. doi: 10.3109/00016341003657918. [DOI] [PubMed] [Google Scholar]
- 2.Chabrolle C, Tosca L, Crochet S, Tesseraud S, Dupont J. Expression of adiponectin and its receptor s (AdipoR1 and AdipoR2) in chicek ovary: Potential role in ovarian steroidogenesis. Domest Anim Endocrinol. 2007;33(4):480–7. doi: 10.1016/j.domaniend.2006.08.002. [DOI] [PubMed] [Google Scholar]
- 3.Chabrolle C, Tosca T, Dupont J. Regulation of adiponectin and its receptor in rat ovary by human chorionic gonadotropihim treatment and potential involvement of adiponectin in granulosa cell steroidogenesis. Reproduction. 2007;133(4):719–31. doi: 10.1530/REP-06-0244. [DOI] [PubMed] [Google Scholar]
- 4.Chabrolle C, Tosca L, Ramé C, Lecomte P, Royère D, Dupont J. Adiponectin increases insulin-like growth factor I-induced progesterone and estradiol secretion in human granulosa cells. Fertil Steril. 2009;92(6):1988–96. doi: 10.1016/j.fertnstert.2008.09.008. [DOI] [PubMed] [Google Scholar]
- 5.Chaudhuri C, Harada Y, Shimizu K, Gut M, Dorfman RI. Biosynthesis of Pregnenolone from 22-Hydroxycholesterol. J Biol Chem. 1962;237(3):703–5. [PubMed] [Google Scholar]
- 6.Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R. Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord. 2002;26(7):883–96. doi: 10.1038/sj.ijo.0801994. [DOI] [PubMed] [Google Scholar]
- 7.Jung M, Ramankulov A, Roigas J, Johannsen M, Ringsdorf M, Kristiansen G, et al. In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real‐time PCR. BMC Mol Biol 2007;8:e47. [DOI] [PMC free article] [PubMed]
- 8.Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005;26(3):439–51. doi: 10.1210/er.2005-0005. [DOI] [PubMed] [Google Scholar]
- 9.Kishida K, Funahashi T, Shimoura I. Molecular mechanisms of diabetes and atherosclerosis; role of adiponectin. Endocr Metab Immune Disord Drug Targets. 2012;12(2):118–31. doi: 10.2174/187153012800493468. [DOI] [PubMed] [Google Scholar]
- 10.Ledoux S, Campos DB, Lopes FL, Dobias-Goff M, Palin MF, Murphy BD. Adiponectin induces periovulatory changes in ovarian follicular cells. Endocrinology. 2006;147(11):5178–86. doi: 10.1210/en.2006-0679. [DOI] [PubMed] [Google Scholar]
- 11.Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2009;302(2):179–88. doi: 10.1001/jama.2009.976. [DOI] [PubMed] [Google Scholar]
- 12.Li L, Yun JH, Lee JH, Song S, Choi BC, Baek KH. Association study of +45G15G(T/G) and +276(G/T) polymorphisms in the adiponectin gene in patients with polycystic ovary syndrome. Int J Mol Med. 2011;27(2):283–7. doi: 10.3892/ijmm.2010.565. [DOI] [PubMed] [Google Scholar]
- 13.Li L, Ferin M, Sauer MV, Lobo RA. Ovarian adipocytokines are associated with early in vitro human embryo development independent of the action of ovarian insulin. J Assist Reprod Genet. 2012;29:1397–1404. [DOI] [PMC free article] [PubMed]
- 14.Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C (T)) method. Methods. 2001;25(4):402–8. doi: 10.1006/meth.2001.1262. [DOI] [PubMed] [Google Scholar]
- 15.McGee EA, Hsueh AJW. Initial and cyclic recruitment of ovarian follicles. Endocr Rev. 2000;21(2):200–14. doi: 10.1210/er.21.2.200. [DOI] [PubMed] [Google Scholar]
- 16.McGee E, Sawetawan C, Bird I, Rainey WE, Carr BR. The effects of insulin on 3 beta- hydroxysteroid dehydrogenase expression in human luteinized granulosa cells. J Soc Gynecol Investig. 1995;2(3):535–41. doi: 10.1016/1071-5576(94)00061-5. [DOI] [PubMed] [Google Scholar]
- 17.Michalakis KG, Segars JH. The role of adiponectin in reproduction: from polycystic ovary syndrome to assisted reproduction. Fertil Steril. 2010;94(6):1949–57. doi: 10.1016/j.fertnstert.2010.05.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Nishida M, Funahashi T, Shimomura I. Pathophysiological significance of adiponectin. Med Mol Morphol. 2007;40(2):55–67. doi: 10.1007/s00795-007-0366-7. [DOI] [PubMed] [Google Scholar]
- 19.Pajvani UB, Scherer PE. Adiponectin: systemic contributor to insulin sensitivity. Curr Diabetes Rep. 2003;3(3):207–13. doi: 10.1007/s11892-003-0065-2. [DOI] [PubMed] [Google Scholar]
- 20.Pierre P, Froment P, Nègre D, Ramé C, Barateau V, Chabrolle C, et al. Role of adiponectin receptors, AdipoR1 and AdipoR2, in the steroidogenesis of the human granulosa tumor cell line, KGN. Hum Reprod. 2009;24(11):2890–901. doi: 10.1093/humrep/dep292. [DOI] [PubMed] [Google Scholar]
- 21.Putz DM, Goldner WS, Bar RS, Haynes WG, Sivitz WI. Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy. Metabolism. 2004;53(11):1454–61. doi: 10.1016/j.metabol.2004.06.013. [DOI] [PubMed] [Google Scholar]
- 22.Richards JS, Liu Z, Kawai T, Tabata K, Watanabe H, Suresh D, et al. Adiponectin and its receptors modulate granulosa cell and cumulus cell functions, fertility, and early embryo development in the mouse and human. Fertil Steril. 2012;98(2):471–9. doi: 10.1016/j.fertnstert.2012.04.050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Scherer PE. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes. 2006;55:1537–45. doi: 10.2337/db06-0263. [DOI] [PubMed] [Google Scholar]
- 24.Tabandeh MR, Golestanib N, Kafi M, Hosseini A, Saeb M, Sarkoohi P. Gene expression pattern of adiponectin and adiponectin receptors in dominant and atretic follicles and oocytes screened based on brilliant cresyl blue staining. Anim Reprod Sci. 2012;131(1–2):30–40. doi: 10.1016/j.anireprosci.2012.02.006. [DOI] [PubMed] [Google Scholar]
- 25.Takikawa S, Iwase A, Goto M, Harata T, Umezu T, Nakahara T, et al. Assessment of the predictive value of follicular fluid insulin, leptin and adiponectin in assisted reproductive cycles. Gynecol Endocrinol. 2010;26(7):494–9. doi: 10.3109/09513591003632050. [DOI] [PubMed] [Google Scholar]
- 26.Tishinsky JM, Dyck DJ, Robinson LE. Lifestyle factors increasing adiponectin synthesis and secretion. Vitam Horm. 2012;90:1–30. doi: 10.1016/B978-0-12-398313-8.00001-4. [DOI] [PubMed] [Google Scholar]
- 27.Toulis KA, Goulis DG, Farmakiotis D, Georgopoulus NA, Katsikis I, Tarlatzis BC, et al. Adiponectin levels in women with polycystic ovary syndrome: a sytematic review and meta-analysis. Hum Reprod Update. 2009;15(3):297–307. doi: 10.1093/humupd/dmp006. [DOI] [PubMed] [Google Scholar]
- 28.Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86(5):1930–5. doi: 10.1210/jc.86.5.1930. [DOI] [PubMed] [Google Scholar]
- 29.Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 2003;423(6941):762–9. doi: 10.1038/nature01705. [DOI] [PubMed] [Google Scholar]